GPs with AstraZeneca stockpile turn attention to vaccinating over-50s Patient concerns around the AstraZeneca vaccine have seen a decline in interest in some practices, prompting GPs to bring forward the new rollout strategy’s commencement date.
Benefits of AstraZeneca overwhelmingly high despite increased clotting risk New European research has found the risk of a rare blood clotting syndrome associated with the vaccine is double what has been previously reported.
Are blood clots a concern with mRNA vaccines? An investigation into Australia’s first case of blood clotting after the Pfizer vaccine has yet to confirm a link.
Blood-clot death ‘likely’ linked to AstraZeneca COVID vaccine The TGA has confirmed the recent death of a 48-year-old NSW woman was likely linked to the vaccine: ‘A causative link to vaccination should be assumed at this time’.
‘No change’ in risk profile with second blood clot case linked to AstraZeneca Two cases of clotting in 700,000 administered doses does not indicate an increased level of risk, experts have said.
Changes to the vaccine rollout: What are the immediate impacts for GPs? Effects of Australia’s pivot from AstraZeneca to Pfizer for people under 50 are being felt as practices work to ease patient concerns.
AstraZeneca blood clot link increases importance of Novavax But with clinical trials progressing slowly, uncertainty remains over when Australia will access the 51 million doses of its third vaccine candidate.
European regulator finds possible link between vaccine and blood clots UPDATED: The European Medicines Agency says it has found a possible link between AstraZeneca’s COVID-19 vaccine and rare blood clotting issues in adults.
ATAGI issues GPs with guidance for clotting condition ‘likely’ linked to COVID vaccine The national advisory body is urging vaccine providers to be aware of post-vaccination warning signs, including new onset of severe persistent headache that is not settling with analgesia.
ATAGI review of AstraZeneca COVID vaccines: What GPs need to know The latest advice suggests there is only a ‘tiny’ risk of blood clots in some patients, but does include contraindications for two rare conditions.